中文

福安药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-27
ItemAmountY/Y
Revenue¥0.41B-12.9%
Gross profit¥0.17B
Operating income¥0.06B
Net income¥0.05B-20.4%
Gross margin40.6%Net margin 13.4%
Revenue Q/Q-3.6%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.24B59.4%
R&D¥0.03B6.4%
SG&A¥0.10B23.8%
Tax & other¥0.00B1.1%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

长荣股份长海股份节能铁汉*ST纳川翰宇药业高盟新材海伦哲聚光科技舒泰神*ST天喻理邦仪器欣旺达

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies